751 results match your criteria Pityriasis Rosea


Pityriasis rosea after mRNA COVID-19 vaccination.

Int J Dermatol 2021 Jun 10. Epub 2021 Jun 10.

Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.

View Article and Full-Text PDF

Intensely Pruritic Rash for Five Weeks.

J Emerg Med 2021 Jun 3. Epub 2021 Jun 3.

Department of Emergency Medicine, University of Texas Southwestern Medical School, Dallas, Texas.

View Article and Full-Text PDF

Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.

J Eur Acad Dermatol Venereol 2021 May 29. Epub 2021 May 29.

Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

View Article and Full-Text PDF

Acral pityriasis rosea: A rare variant of pityriasis rosea.

Dermatol Reports 2021 Mar 13;13(1):9081. Epub 2021 May 13.

Institute of Dermatology, Ministry of Public Health, Thailand.

View Article and Full-Text PDF

Pityriasis Rosea in a Confirmed COVID-19 Pediatric Patient.

Actas Dermosifiliogr 2021 May 15. Epub 2021 May 15.

Departamento de Patología, Facultad de Medicina, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.

View Article and Full-Text PDF

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.

J Eur Acad Dermatol Venereol 2021 May 13. Epub 2021 May 13.

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

View Article and Full-Text PDF

International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries.

Int J Dermatol 2021 May 8. Epub 2021 May 8.

Departamento de Dermatología, Instituto de Biomedicina, Universidad Central de Venezuela, Hospital Vargas Clínica El Ávila, Caracas, Venezuela.

Background: The infection by coronavirus disease 2019 (COVID-19) has been associated with multiple cutaneous manifestations, although characterization of them in Hispanic patients with darker skin phototypes is lacking. The objective of this study is to characterize the clinical dermatological manifestations associated with COVID-19 infection in cases with few or without general symptoms in patients from Latin America.

Methods: Cross-sectional study using a questionnaire that was made for health professionals (physicians with a specialty in dermatology) to investigate dermatological lesions associated with COVID-19 infection in patients from 25 countries of Latin America. Read More

View Article and Full-Text PDF

Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.

J Eur Acad Dermatol Venereol 2021 Apr 29. Epub 2021 Apr 29.

Department of Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey.

View Article and Full-Text PDF

Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.

Br J Dermatol 2021 Apr 26. Epub 2021 Apr 26.

Faculty of Medicine and Biomedical Sciences, University of Algarve, Faro, Portugal.

View Article and Full-Text PDF

Cutaneous Manifestations of COVID-19.

Cutis 2021 Feb;107(2):90-94

Ms. Schwartzberg is from the New York Institute of Technology College of Osteopathic Medicine, Old Westbury. Dr. Lin is from the Department of Dermatology, St. John's Episcopal Hospital, Far Rockaway, New York. Dr. Jorizzo is from the Department of Dermatology, Wake Forest Baptist Health, Winston-Salem, North Carolina, and Weill Cornell Medicine Dermatology, New York, New York.

Patients with coronavirus disease 2019 (COVID-19) present with multisystem signs and symptoms, including dermatologic manifestations. The recent literature has revealed that dermatologic manifestations of COVID-19 often are early onset and provide helpful cues to a timely diagnosis. We compiled the relevant emerging literature regarding the dermatologic manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) so that physicians can be aware of the various clinical cutaneous presentations in this time of high incidence of COVID-19. Read More

View Article and Full-Text PDF
February 2021

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

J Am Acad Dermatol 2021 07 7;85(1):46-55. Epub 2021 Apr 7.

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

Background: Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines have been reported but are not well characterized.

Objective: To evaluate the morphology and timing of cutaneous reactions after mRNA COVID-19 vaccines.

Methods: A provider-facing registry-based study collected cases of cutaneous manifestations after COVID-19 vaccination. Read More

View Article and Full-Text PDF

Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.

Medicine (Baltimore) 2021 Apr;100(14):e25352

Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, Academic Emergency Hospital Sibiu - Dermatology Clinic, Sibiu, Romania.

Rationale: Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. The etiopathogenesis of PR is still unknown, but is frequently associated with episodes of upper respiratory tract infections. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Read More

View Article and Full-Text PDF

Symmetric blaschkoid pityriasis rosea in a child.

Pediatr Dermatol 2021 Mar 19. Epub 2021 Mar 19.

Department of Dermatology, Venereology, and Leprosy, R.G.Kar Medical College, Kolkata, India.

Pityriasis rosea (PR) is a common papulosquamous disorder that may be related to primary infection or endogenous reactivation of human herpesvirus 7 and 6. Based on morphology, distribution, and size of lesions, several atypical variants of PR have been described. PR following the lines of Blaschko represents an atypical variant that has seldom been described in the literature. Read More

View Article and Full-Text PDF

Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor.

Actas Dermosifiliogr (Engl Ed) 2021 Mar 3. Epub 2021 Mar 3.

Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Cádiz, España.

View Article and Full-Text PDF

Dermoscopy Differentiates Guttate Psoriasis from a Mimicker-Pityriasis Rosea.

Dermatol Pract Concept 2021 Jan 29;11(1):e2021138. Epub 2021 Jan 29.

Department of Pathology, HBT Medical College & Dr. R.N. Cooper Hospital, Mumbai, India.

Background: Guttate psoriasis (GP) and pityriasis rosea (PR) are a part of papulosquamous disorders that have very similar clinical features and often require histopathology to confirm the diagnosis. Dermoscopy has emerged as a noninvasive, cost-effective technique that can aid in the diagnosis of inflammatory skin diseases like GP and PR.

Objective: To study and compare the dermoscopic features of GP and PR. Read More

View Article and Full-Text PDF
January 2021

A convolutional neural network architecture for the recognition of cutaneous manifestations of COVID-19.

Dermatol Ther 2021 Mar 28;34(2):e14902. Epub 2021 Feb 28.

Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.

During the COVID-19 pandemic, dermatologists reported an array of different cutaneous manifestations of the disease. It is challenging to discriminate COVID-19-related cutaneous manifestations from other closely resembling skin lesions. The aim of this study was to generate and evaluate a novel CNN (Convolutional Neural Network) ensemble architecture for detection of COVID-19-associated skin lesions from clinical images. Read More

View Article and Full-Text PDF

A multiplex real-time PCR quantitation of human herpesvirus-6, 7, 8 viruses: application in blood transfusions.

Virol J 2021 02 18;18(1):38. Epub 2021 Feb 18.

Department of Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, Hubei, China.

Background: In recent years, fluorescent quantitative polymerase chain reaction assays for detecting viral DNA are in widespread use throughout the world. However, considering the wide distribution of new herpesvirus among the population, we constructed a method to detect HHV-6, 7, and 8 simultaneously.

Methods: The blood samples of 74 blood donors and 45 pityriasis rosea patients were collected. Read More

View Article and Full-Text PDF
February 2021

Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends.

Dermatol Ther 2021 Mar 25;34(2):e14895. Epub 2021 Feb 25.

Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.

Coronavirus disease 2019 (COVID-19) pandemic had substantial effect both on daily life and medical practice. Internet data have been used to analyze the trends in public interest in various medical conditions and treatments. The aim of this study is to analyze the public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic. Read More

View Article and Full-Text PDF

Cutaneous manifestations of COVID-19.

Dermatol Online J 2021 Jan 15;27(1). Epub 2021 Jan 15.

Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.

The severe acute respiratory syndrome coronavirus two (SARS-CoV-2), which causes the 2019 coronavirus disease (COVID-19), has infected patients worldwide. Physicians have increasingly identified cutaneous findings as a significant clinical manifestation of COVID-19. In this review, we describe the clinical presentation, onset, duration, associated symptoms, treatment, and outcome of cutaneous manifestations thus far reported to be related to COVID-19. Read More

View Article and Full-Text PDF
January 2021

Dermoscopy in general dermatology (non-neoplastic dermatoses): pitfalls and tips.

Authors:
Enzo Errichetti

Int J Dermatol 2021 Jun 3;60(6):653-660. Epub 2021 Feb 3.

Institute of Dermatology, "Santa Maria della Misericordia" University Hospital, Udine, Italy.

Background: Dermoscopy is gaining appreciation in the spectrum of non-neoplastic skin conditions, especially papulosquamous and granulomatous dermatoses. However, the use of dermoscopy in such diseases has not yet acquired a standard role in daily practice due to the lack of a structured approach as well as possible pitfalls limiting its accuracy.

Methods: A descriptive analysis of the most common limitations/pitfalls described in the literature regarding dermoscopy of non-neoplastic dermatoses was performed, also providing possible tips to deal with them. Read More

View Article and Full-Text PDF

SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.

Br J Dermatol 2021 06 4;184(6):1194-1195. Epub 2021 Mar 4.

Internal Medicine Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.

View Article and Full-Text PDF

Dermoscopy of common papulosquamous dermatoses varies between dark (III and IV) and very dark (V and VI) skin phototypes.

Authors:
Enzo Errichetti

Dermatol Ther 2021 03 12;34(2):e14757. Epub 2021 Jan 12.

Institute of Dermatology, "Santa Maria della Misericordia" University Hospital, Udine, Italy.

View Article and Full-Text PDF

Pigmented purpuric dermatosis: Ten years of experience in a tertiary hospital and awareness of mycosis fungoides in differential diagnosis.

J Cutan Pathol 2021 May 18;48(5):611-616. Epub 2021 Jan 18.

Department of Pathology, Istanbul Haseki Training and Research Hospital, Istanbul, Turkey.

Background: Pigmented purpuric dermatoses (PPD) can clinically mimic many diseases. Histopathology provides a definitive diagnosis. The aim of the study is to reveal the features of patients with PPD and to determine the disease frequency in the differential diagnosis, especially mycosis fungoides (MF). Read More

View Article and Full-Text PDF

L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.

Dermatol Ther 2021 01 30;34(1):e14679. Epub 2020 Dec 30.

Department of Biosciences, Piracicaba Dental School - UNICAMP, Piracicaba, Brazil.

Pityriasis rosea (PR) is a dermatological disease with an erythemato-papulosquamous manifestation, distributed on the trunk and extremities affecting healthy people, especially children and young people between 10 and 35 years of age. The evolution is 6 to 8 weeks and may remain for 3 to 6 months. It regresses spontaneously and can leave changes in the skin color but reversibly. Read More

View Article and Full-Text PDF
January 2021

Dermoscopic characterization of guttate psoriasis, pityriasis rosea, and pityriasis lichenoides chronica in dark skin phototypes: An observational study.

Dermatol Ther 2021 01 13;34(1):e14631. Epub 2020 Dec 13.

Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.

Dermoscopy as a diagnostic tool is attaining impetus in inflammatory dermatoses with the cumulative description of characteristic findings in most dermatoses obviating at times the need of biopsy. In this retrospective observational study, 20 histopathology confirmed cases each of pityriasis rosea (PR), guttate psoriasis (GP), and pityriasis lichenoides chronica (PLC) seen over a period of 3 years were included. Dermoscopy images were extracted from photography archives for evaluation and three lesions from each patient (60 lesions each) were analyzed. Read More

View Article and Full-Text PDF
January 2021

Pityriasis rosea as a leading manifestation of COVID-19 infection.

J Eur Acad Dermatol Venereol 2021 Apr 23;35(4):e246-e247. Epub 2020 Dec 23.

Department of Dermatology, Hotel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

View Article and Full-Text PDF